Hearing News Watch

HAUPPAUGE, NEW YORK — Monica Dreger, the Global Head of Research at Airbnb, stands out for her intuitive approach and finely honed listening skills. With a background in behavioral psychology, Dreger’s career has been dedicated to understanding consumer behavior and strategic planning for major brands like Mattel, Nickelodeon, and Unilever. Despite her professional success, Dreger’s personal journey with hearing loss

MONTPELLIER, FRANCE —  Sensorion (FR0012596468 – ALSEN), a leading clinical-stage biotechnology company specializing in innovative therapies for hearing-related conditions, has announced the successful recruitment of the final participant in its Phase 2a clinical trial of SENS-401. This trial aims to evaluate the efficacy of SENS-401 in preserving residual hearing in adult patients undergoing cochlear implantation. Preserving Residual Hearing in Cochlear

CQ Partners, a long-time leader in hearing healthcare has made a major industry announcement: CQ Partners is NOT a buying group. Instead, they insist, they are a Growth Partner. “The industry label, buying group, has never fit us. We exist to add value and help good practices become great practices. The status quo just doesn’t cut it anymore and that’s

BLOOMINGTON, MINNESOTA – In recognition of Black History Month, GN will once again donate a portion of proceeds from top-level ReSound Nexia, Beltone Serene and Audigy AGXR XF hearing aids sold in the U.S. in February to the GN Hearing Scholarship fund. The GN Hearing Scholarship started in 2021 to help improve diversity in hearing healthcare by supporting Black students pursuing a

Milan, 31 January 2024 – The Amplifon Foundation has launched its Kindness Manifesto, aiming to foster contemplation on kindness as a fundamental value in human interactions. This initiative, unveiled on the occasion of the non-profit organization’s fourth anniversary, coincides with the release of a podcast by Mario Calabresi and Chora Media, delving into the diverse interpretations of kindness with esteemed

SEATTLE, WASHINGTON — Sound Pharmaceuticals (SPI) will unveil Phase 2b STOP Ototoxicity data, chosen for a podium presentation at the Association for Research in Otolaryngology (ARO) Midwinter Meeting in Anaheim, CA (February 3-7). This study examined the safety and efficacy of SPI-1005 (ebselen) in preventing and treating aminoglycoside-induced ototoxicity in 60 adult CF patients undergoing intravenous (IV) tobramycin for acute

The Tinnitus Relief Summit, a free, annual gathering for individuals with ringing in the ears is set to stream on February 7th and February 8th. Each day will have a unique panel of tinnitus experts, who will share their latest research-based findings and actionable tips for how to reduce tinnitus and thrive. This annual event, taking place during Tinnitus Awareness

In a new study published this week in The Lancet Regional Health – Americas reveals stark geographic divides in hearing loss prevalence across the United States. Researchers at NORC at the University of Chicago estimated hearing loss rates not just nationwide, but also at the state and county levels for the first time. The results show hearing loss impacts rural

PHILADELPHIA, PENNSYLVANIA — Children’s Hospital of Philadelphia (CHOP) announced the initial results of an experimental gene therapy treatment for a patient with hereditary hearing loss in the United States. Findings to date indicate the treatment was successful. While the specific gene involved is quite rare, the milestone represents a breakthrough in treating patients around the world with hearing loss caused

INDIANAPOLIS, INDIANA — Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), announced positive initial clinical results from the Phase 1/2 AK-OTOF-101 study, which demonstrated restored hearing within 30 days of AK-OTOF administration in the first participant, an individual with over a decade of profound hearing loss. Results, including initial data from a second participant who